EMEA-000482-PIP01-08-M06 - paediatric investigation plan
teduglutide
PIPHuman
Takeda Pharmaceuticals International AG Ireland Branch
E-mail: medinfoemea@takeda.com
Tel: +44 (0) 3333 000181
P/0479/2020 : EMA decision of 1 December 2020 on the acceptance of a modification of an agreed paediatric investigation plan for teduglutide (Revestive) (EMEA-000482-PIP01-08-M06)